» Articles » PMID: 35312907

Effects of Acute Ischemia and Hypoxia in Young and Adult Calsequestrin (CSQ2) Knock-out and Wild-type Mice

Overview
Publisher Springer
Specialty Biochemistry
Date 2022 Mar 21
PMID 35312907
Authors
Affiliations
Soon will be listed here.
Abstract

Calsequestrin (CSQ2) is the main Ca-binding protein in the sarcoplasmic reticulum of the mammalian heart. In order to understand the function of calsequestrin better, we compared two age groups (young: 4-5 months of age versus adult: 18 months of age) of CSQ2 knock-out mice (CSQ2(-/-)) and littermate wild-type mice (CSQ2(+/+)). Using echocardiography, in adult mice, the basal left ventricular ejection fraction and the spontaneous beating rate were lower in CSQ2(-/-) compared to CSQ2(+/+). The increase in ejection fraction by β-adrenergic stimulation (intraperitoneal injection of isoproterenol) was lower in adult CSQ2(-/-) versus adult CSQ2(+/+). After hypoxia in vitro (isolated atrial preparations) by gassing the organ bath buffer with 95% N, force of contraction in electrically driven left atria increased to lower values in young CSQ2(-/-) than in young CSQ2(+/+). In addition, after global ischemia and reperfusion (buffer-perfused hearts according to Langendorff; 20-min ischemia and 15-min reperfusion), the rate of tension development was higher in young CSQ2(-/-) compared to young CSQ2(+/+). Finally, we evaluated signs of inflammation (immune cells, autoantibodies, and fibrosis). However, whereas no immunological alterations were found between all investigated groups, pronounced fibrosis was found in the ventricles of adult CSQ2(-/-) compared to all other groups. We suggest that in young mice, CSQ2 is important for cardiac performance especially in isolated cardiac preparations under conditions of impaired oxygen supply, but with differences between atrium and ventricle. Lack of CSQ2 leads age dependently to fibrosis and depressed cardiac performance in echocardiographic studies.

Citing Articles

Comparison of Cardioprotective Potential of Cannabidiol and β-Adrenergic Stimulation Against Hypoxia/Reoxygenation Injury in Rat Atria and Ventricular Papillary Muscles.

Pedzinska-Betiuk A, Gergs U, Weresa J, Remiszewski P, Harasim-Symbor E, Malinowska B Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459019 PMC: 11509923. DOI: 10.3390/ph17101379.

References
1.
Maclennan D, Wong P . Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc Natl Acad Sci U S A. 1971; 68(6):1231-5. PMC: 389160. DOI: 10.1073/pnas.68.6.1231. View

2.
Gergs U, Fahrion C, Bock P, Fischer M, Wache H, Hauptmann S . Evidence for a functional role of calsequestrin 2 in mouse atrium. Acta Physiol (Oxf). 2016; 219(3):669-682. DOI: 10.1111/apha.12766. View

3.
Pinto A, Paolicelli R, Salimova E, Gospocic J, Slonimsky E, Bilbao-Cortes D . An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS One. 2012; 7(5):e36814. PMC: 3349649. DOI: 10.1371/journal.pone.0036814. View

4.
Jones L, Suzuki Y, Wang W, Kobayashi Y, Ramesh V, Franzini-Armstrong C . Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest. 1998; 101(7):1385-93. PMC: 508716. DOI: 10.1172/JCI1362. View

5.
Knollmann B, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K . Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006; 116(9):2510-20. PMC: 1551934. DOI: 10.1172/JCI29128. View